Drugs that contain Glycerol Phenylbutyrate
1. Ravicti patents expiration
RAVICTI Litigations
Can you believe RAVICTI received compensation for the extended wait time during the regulatory approval process?
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9962359 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Sep, 2030
(6 years from now) | |
| US10668040 | HORIZON THERAP | Treatment of urea cycle disorders in neonates and infants |
Sep, 2030
(6 years from now) | |
| US10183006 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Sep, 2030
(6 years from now) | |
| US10183005 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Sep, 2030
(6 years from now) | |
| US9561197 | HORIZON THERAP | Methods of therapeutic monitoring of phenylacetic acid prodrugs |
Sep, 2030
(6 years from now) | |
| US10183003 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Sep, 2030
(6 years from now) | |
| US10183002 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Sep, 2030
(6 years from now) | |
| US10183004 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Sep, 2030
(6 years from now) | |
| US10045958 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Sep, 2030
(6 years from now) | |
| US8642012 | HORIZON THERAP | Methods of treatment using ammonia-scavenging drugs |
Sep, 2030
(6 years from now) | |
| US10045959 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Sep, 2030
(6 years from now) | |
| US9999608 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Sep, 2030
(6 years from now) | |
| US9254278 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Mar, 2032
(8 years from now) | |
| US9095559 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Mar, 2032
(8 years from now) | |
| US8404215 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging |
Mar, 2032
(8 years from now) | |
| US9326966 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Mar, 2032
(8 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity (ODE) | Apr 28, 2024 |
Market Authorisation Date: 01 February, 2013
Treatment: Treatment of a urea cycle disorder; Dosage adjustment of a nitrogen scavenging drug in the treatment of a urea cycle disorder
Dosage: LIQUID;ORAL
How can I launch a generic of RAVICTI before it's drug patent expiration?
More Information on Dosage
RAVICTI family patents
